Norway· NO-ID_277D3349-90AE-4561-898C-7D7EAC761FF0
Orgovyx
A relugolix product containing relugolix, registered in Norway by 2care4 ApS. The same ATC class is registered in 15 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Relugolix is registered in 15 of 19 countries.
Countries holding a registration under ATC L02BX04 (relugolix), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 10 of them publish a price we can compare per daily dose
Relugolix · ATC L02BX04
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of relugolix costs, country by country.
Normalised to the WHO defined daily dose (0.12 g), the median price runs from $3.40 in France to $9.83 in Italy — a ×2.9 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Relugolix · price per daily dose (0.12 g)
USD · FX 28 Sept 2026
- IT Italy$9.83
- ES Spain$7.69
- CH Switzerland$6.03
- FR France$3.40
The record
At a glance
FEST (Norway)- Active substance
- Relugolix
- Manufacturer
- 2care4 ApS
- Country
- Norway (NO)
- ATC code
- L02BX04
- ATC class
- Relugolix
- Defined daily dose
- 0.12 g, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_277D3349-90AE-4561-898C-7D7EAC761FF0
- no_varenummer08597630NOK 1674.6
- gtin5712923038712
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
168 interactions on record for relugolix.
Graded by severity as the source publishes them — 52 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Relugolix · interactions on record
168 records
- 52 severe
- 101 moderate
- 15 minor
Most severe, free to view
- PapaverineA03AD01severe
- DolasetronA04AA04severe
- RolapitantA04AD14severe
- FidaxomicinA07AA12severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Relugolix in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaORGOVYXAccord Healthcare S.L.U., Barcelona
- FinlandOrgovyxAbacus Medicine A/S
- SpainORGOVYX 120 MG COMPRIMIDOS RECUBIERTOS CON PELICULAAccord Healthcare S.L.U.
- FranceORGOVYX 120 mg, comprimé pelliculéACCORD HEALTHCARE (ESPAGNE)
- IrelandOrgovyx 120 mg film-coated tabletsAccord Healthcare S.L.U.
- IcelandOrgovyxAccord Healthcare S.L.U.
- NetherlandsOrgovyx 120 mg, filmomhulde tablettenAccord Healthcare S.L.U.
- PolandOrgovyxAccord Healthcare S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Orgovyx
- Liechtenstein · Orgovyx
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/69463b6c-bacb-4087-8619-d9275a76e6a4 GET /v1/drugs/69463b6c-bacb-4087-8619-d9275a76e6a4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablett, filmdrasjert",
"source": "fest",
"status": "A",
"atc_name": "Relugoliks",
"merkevare_id": "ID_277D3349-90AE-4561-898C-7D7EAC761FF0",
"name_form_strength": "Orgovyx tab 120 mg",
"prescription_group": "C"
}See everything about relugolix.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.